Cinclus Pharma Holding AB (OSTO:CINPHA) EV-to-EBIT : -2.30 (As of Dec. 11, 2024)

Cinclus Pharma Holding AB EV-to-EBIT Chart

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-EBIT	Get a 7-Day Free Trial				-	-	-	-4.32	-4.33

Competitive Comparison of Cinclus Pharma Holding AB's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cinclus Pharma Holding AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cinclus Pharma Holding AB's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cinclus Pharma Holding AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cinclus Pharma Holding AB's EV-to-EBIT falls into.

Cinclus Pharma Holding AB EV-to-EBIT Calculation

Cinclus Pharma Holding AB's EV-to-EBIT for today is calculated as:

Cinclus Pharma Holding AB's current Enterprise Value is kr351.39 Mil.
Cinclus Pharma Holding AB's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-152.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cinclus Pharma Holding AB  (OSTO:CINPHA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cinclus Pharma Holding AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Cinclus Pharma Holding AB's Enterprise Value for the quarter that ended in Sep. 2024 was kr660.63 Mil.
Cinclus Pharma Holding AB's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-152.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cinclus Pharma Holding AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description